| Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised … S Rts Lancet 386 (9988), 31-45, 2015 | 2424* | 2015 |
| Phase 1 trials of rVSV Ebola vaccine in Africa and Europe ST Agnandji, A Huttner, ME Zinser, P Njuguna, C Dahlke, JF Fernandes, ... New England Journal of Medicine 374 (17), 1647-1660, 2016 | 520 | 2016 |
| Sterile protection against human malaria by chemoattenuated PfSPZ vaccine B Mordmüller, G Surat, H Lagler, S Chakravarty, AS Ishizuka, ... Nature 542 (7642), 445-449, 2017 | 467 | 2017 |
| Efficacy and safety of the RTS, S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites RTS, S Clinical Trials Partnership (2014) PLoS medicine 11 (7), e1001685, 2014 | 467 | 2014 |
| Atypical and classical memory B cells produce Plasmodium falciparum neutralizing antibodies MF Muellenbeck, B Ueberheide, B Amulic, A Epp, D Fenyo, CE Busse, ... Journal of Experimental Medicine 210 (2), 389-399, 2013 | 247 | 2013 |
| Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines TL Richie, PF Billingsley, BKL Sim, ER James, S Chakravarty, JE Epstein, ... Vaccine 33 (52), 7452-7461, 2015 | 229 | 2015 |
| Nitric Oxide Synthase 2Lambaréné (G‐954C), Increased Nitric Oxide Production, and Protection against Malaria JF Kun, B Mordmüller, DJ Perkins, J May, O Mercereau‐Puijalon, ... The Journal of infectious diseases 184 (3), 330-336, 2001 | 227 | 2001 |
| Hemozoin (malarial pigment) inhibits differentiation and maturation of human monocyte-derived dendritic cells: a peroxisome proliferator-activated receptor-γ-mediated effect OA Skorokhod, M Alessio, B Mordmuller, P Arese, E Schwarzer The Journal of Immunology 173 (6), 4066-4074, 2004 | 224 | 2004 |
| Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria JFJ Kun, B Mordmüller, B Lell, LG Lehman, D Luckner, PG Kremsner The Lancet 351 (9098), 265-266, 1998 | 224 | 1998 |
| The IκB Kinase Complex and NF-κB Actas Master Regulators of Lipopolysaccharide-Induced Gene Expressionand Control Subordinate Activation ofAP-1 D Krappmann, E Wegener, Y Sunami, M Esen, A Thiel, B Mordmuller, ... Molecular and cellular biology 24 (14), 6488-6500, 2004 | 188 | 2004 |
| Lymphotoxin and lipopolysaccharide induce NF‐κB‐p52 generation by a co‐translational mechanism B Mordmüller, D Krappmann, M Esen, E Wegener, C Scheidereit EMBO reports 4 (1), 82-87, 2003 | 186 | 2003 |
| Natural infection of Plasmodium brasilianum in humans: man and monkey share quartan malaria parasites in the Venezuelan Amazon A Lalremruata, M Magris, S Vivas-Martínez, M Koehler, M Esen, ... EBioMedicine 2 (9), 1186-1192, 2015 | 180 | 2015 |
| Selection of a trioxaquine as an antimalarial drug candidate F Coslédan, L Fraisse, A Pellet, F Guillou, B Mordmüller, PG Kremsner, ... Proceedings of the National Academy of Sciences 105 (45), 17579-17584, 2008 | 176 | 2008 |
| Neutrophil extracellular traps drive inflammatory pathogenesis in malaria SL Knackstedt, A Georgiadou, F Apel, U Abu-Abed, CA Moxon, ... Science immunology 4 (40), eaaw0336, 2019 | 163 | 2019 |
| Experimental infection of human volunteers M Roestenberg, MA Hoogerwerf, DM Ferreira, B Mordmüller, ... The Lancet Infectious Diseases 18 (10), e312-e322, 2018 | 163 | 2018 |
| Safety and immunogenicity of GMZ2—a MSP3–GLURP fusion protein malaria vaccine candidate M Esen, PG Kremsner, R Schleucher, M Gässler, EB Imoukhuede, ... Vaccine 27 (49), 6862-6868, 2009 | 161 | 2009 |
| First-in-human, randomized, double-blind clinical trial of differentially adjuvanted PAMVAC, a vaccine candidate to prevent pregnancy-associated malaria B Mordmüller, M Sulyok, D Egger-Adam, M Resende, WA de Jongh, ... Clinical Infectious Diseases 69 (9), 1509-1516, 2019 | 155 | 2019 |
| Natural parasite exposure induces protective human anti-malarial antibodies G Triller, SW Scally, G Costa, M Pissarev, C Kreschel, A Bosch, E Marois, ... Immunity 47 (6), 1197-1209. e10, 2017 | 152 | 2017 |
| Clonal selection drives protective memory B cell responses in controlled human malaria infection R Murugan, L Buchauer, G Triller, C Kreschel, G Costa, ... Science immunology 3 (20), eaap8029, 2018 | 151 | 2018 |
| Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS, S/AS01E malaria vaccine efficacy C Dobaño, H Sanz, H Sorgho, D Dosoo, M Mpina, I Ubillos, R Aguilar, ... Nature communications 10 (1), 2174, 2019 | 149 | 2019 |